FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer

Platinum compounds in children with cancer

(2013) Antonio Ruggiero et al.   ANTI-CANCER DRUGS

DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells

(2013) Ran Zhao et al.   MOLECULAR CANCER RESEARCH

FOX(M1) News--It Is Cancer

(2013) M. Halasi et al.   MOLECULAR CANCER THERAPEUTICS

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

(2012) Neife Aparecida Guinaim dos Santos et al.   ARCHIVES OF TOXICOLOGY

FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair

(2012) Yun-Yong Park et al.   CARCINOGENESIS

Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer

(2012) A. J. Ziebarth et al.   CLINICAL CANCER RESEARCH

FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

(2012) N. Zhang et al.   CLINICAL CANCER RESEARCH

Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions

(2012) Nozomi Tomimatsu et al.   DNA REPAIR

DNA damage checkpoints in stem cells, ageing and cancer

(2012) Tobias Sperka et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression

(2012) Hongwu Zhu et al.   PLoS One

Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage

(2012) Marianna Halasi et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multiple faces of FoxM1 transcription factor

(2011) Tanya V. Kalin et al.   CELL CYCLE

Mismatch Repair Proteins MSH2, MLH1, and EXO1 Are Important for Class-Switch Recombination Events Occurring in B Cells That Lack Nonhomologous End Joining

(2011) J. Eccleston et al.   JOURNAL OF IMMUNOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells

(2011) Gabriel T. M. Lok et al.   PLoS One

Retention of γH2AX foci as an indication of lethal DNA damage

(2011) Peggy L. Olive   RADIOTHERAPY AND ONCOLOGY

FoxM1 Mediates Resistance to Herceptin and Paclitaxel

(2010) Janai R. Carr et al.   CANCER RESEARCH

The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity

(2010) V. A. Carozzi et al.   CURRENT CANCER DRUG TARGETS

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

(2010) J. M.-M. Kwok et al.   MOLECULAR CANCER RESEARCH

The DNA Damage Response: Making It Safe to Play with Knives

(2010) Alberto Ciccia et al.   MOLECULAR CELL

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

(2009) David S. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks

(2009) Emma Bolderson et al.   NUCLEIC ACIDS RESEARCH

Sgs1 Helicase and Two Nucleases Dna2 and Exo1 Resect DNA Double-Strand Break Ends

(2008) Zhu Zhu et al.   CELL